Notification of full year trading update

Sinclair Pharma plc – Notification of full year trading update   London, 05 January 2017 Sinclair Pharma plc (SPH.L), (“Sinclair”) the international Aesthetics company, will be publishing a trading update for the year ending 31 December 2016 on 17 January 2017.   For further information please contact: Sinclair Pharma plc … Read more

Second Interim Results Presentation (Jan-Jun 2016)

Download our Second Interim Results Presentation About Sinclair Pharma plc  Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high … Read more

Second Interim Statement (Jan-Jun 2016)

Sinclair Pharma plc (SPH.L), (“Sinclair”, or the “Group”, or the “Company”) the international specialty pharma company, today announces its unaudited results for the six and twelve month periods ended 30 June 2016. Delivering strong growth, completed transformational US distribution deal, on track to meet full year guidance Highlights Reported revenues … Read more

Sinclair Pharma plc Restructuring programme and Board change

London, 1 September 2016 Sinclair Pharma plc (SPH.L), (“Sinclair” or the “Company”) the international aesthetics company, today announces that a comprehensive staff restructuring programme has recently been implemented. Sinclair expects to incur a one-off restructuring charge of £2.8m in relation to this programme, the full amount of which will be … Read more

Trading update

Trading update and notification of board changes London, 19 July 2016 Sinclair Pharma plc (SPH.L), (“Sinclair” or the “Company”) the international aesthetics company, today provides a trading update for the six months ended 30 June 2016. Following the Company’s change of year-end to 31 December, this period constitutes the second … Read more

Sinclair CEO Chris Spooner talks InstaLift on Modern Aesthetics TV

Chris Spooner talks with Steven Dayan, MD, FACS about bringing Silhouette InstaLift to the US.  InstaLift differs from other generations of sutures because it’s resorbable and has cones that hook the subdermal fat layer to reposition volume under the skin. The company has other products in the pipeline, including a biphasic hyaluronic … Read more

Transformational US Distribution Agreement

Sinclair Pharma plc signs transformational US collaboration with Almirall’s aesthetics subsidiary Thermi, completion of strategic review, end of offer period and provides positive trading update Transformational US distribution and strategic marketing agreement with Thermi for Silhouette InstaLift™ delivers immediate access through 55 sales reps to the world’s largest aesthetics market Complements … Read more